The present invention relates to an endoprosthesis and a method of manufacturing an endoprosthesis according to the preamble of the independent claims.
Endoprostheses, in particular vascular and heart stents, are used to support blood vessels in the human body. For example, occlusions or aneurysms can be treated by placing such an endoprosthesis at the respective treatment site. In the treatment of an occlusion, the endoprosthesis keeps the vessel open for unhindered blood flow. In the case of an aneurysm, the endoprosthesis can prevent circulation of blood into the aneurysm and thus lower the risk of a thrombus, rupture or further growth of the aneurysm.
It is known in the prior art to use thrombogenic elements on endoprostheses. For example, WO 2013/182614 A1 discloses an endoprosthesis with thrombogenic elements that extend away from a body of the endoprosthesis and promote thrombosis. This allows for the occlusion of an aneurysm to enhance the above-mentioned treatment effect.
WO 2006/0166167 discloses fibers arranged on an endovascular prosthesis.
WO 2019/122944 discloses the attachment of a strip of fabric on with fibers on a stent graft.
DE 195 31 659 discloses a stent wire which comprises fibers. The fibers are attached to the wire structure by being held between two wires that form a spiral. In particular, the fibers of DE 195 31 659 are arranged on the wire used to produce the stent structure. They cannot be attached to the stent post-production.
Currently known methods hence do not provide a simple way of post-production arrangement of thrombogenic elements on an endoprosthesis. Fixation and attachment of thrombogenic elements is usually cumbersome and difficult, and not typically versatile. In addition, known endoprosthesis are limited to generic thrombus generation means that are not adapted to patient-specific needs.
Thus, the object of the present invention is to overcome the drawbacks of the prior art, in particular to provide an alternative mechanism to attach a fiber to an endoprosthesis in a simple, cheap and reliable way.
This and other objects are achieved by the endoprosthesis and the methods according to the characterizing portion of the independent claims.
The endoprosthesis according to the invention may in particular be a vascular or a heart stent. The endoprosthesis comprises a graft, a stent structure, a fiber, and a suture. The suture fixedly attaches the stent structure to the graft. The fiber is attacked to the endoprosthesis via the suture. Such an endoprosthesis is particularly advantageous because the fiber attachment is completely independent from the selection of graft and stent structure. Any type of fiber may be attached to any type the endoprosthesis, regardless of the selection of the stent structure and graft. It also allows for the stent and/or the graft to be pretreated by any treatment, such as heat, plasma, pressure, or radiation, that may otherwise damage the fibers or an attachment mechanism for the fibers.
The fiber may be attached to the stent structure and to the graft via the suture.
The fiber may be a thrombogenic fiber. The thrombogenic fiber may extend, at least partly, away from the surface of the graft and/or stent structure. The thrombogenic fiber may have a free portion, for example a free end, that extends a certain distance away (e.g. outwardly away) from the surface of the graft and/or stent structure. The thrombogenic fiber may, in use, promote thrombosis in a region around or adjacent the endoprosthesis, for example, thrombosis in an aneurysm as explained above. For example, the thrombogenic fiber may have a length of at least 2 mm, optionally between 2 mm and 50 mm. Additionally or alternatively, for example, the thrombogenic fiber may have a free portion having a length of, and/or that can extend a distance away from a surface of the graft and/or stent structure by, at least 2 mm, optionally between 2 mm and 50 mm.
The suture may retain attachment of the fiber to the stent structure and/or graft after implantation of the endoprosthesis. This can keep the thrombogenic effect in the intended placement within the anatomy.
The fiber (e.g. thrombogenic fiber) may be distinct from the graft. Additionally or alternatively, the fiber (e.g. thrombogenic fiber) may be distinct from the suture.
The fiber may comprise or consist of any suitable material for the desired application, for example Dacron, polyethylene, polypropylene, polytetrafluoroethylene, a polyamide (for example, Nylon), polyglycolic-lactic acid or another biocompatible polymer with a thrombogenic effect. However, metals and ceramics are also conceivable as fiber materials.
The suture is preferably a surgical thread known in the art. Alternatively, the suture may also be substantially identical to the fiber, or made of another material.
The suture and the fiber also may be made of the same material and configured integrally.
Preferably, the suture has a knot. The knot may in particular form the suture into a substantially closed loop holding together the stent structure and the graft. This allows for a high degree of flexibility in the attachment of stent and graft, but also a firm attachment of fiber to the endoprosthesis. A substantially closed loop with a knot may be arranged at any desired position on the endoprosthesis.
The substantially closed loops may be arranged as separate, discrete loops that are not connected to other loops.
Preferably, the knot connects the suture to the fiber. The fiber may be configured as a separate element attached by the knot. Alternatively, in particular if the fiber and the suture are made of the same material and/or formed integrally, the free ends of the suture extending away from the knot may be the fibers.
The fiber may form a loop around the suture. The loop may be a substantially closed loop, or a loop that is not closed. The loop may be fixed by a knot, an adhesive, a mechanical fixation, or another fixation mechanism. Alternatively, the loop may only loosely loop around the suture, as a closed loop or as a loop that is not closed.
Preferably, the suture forms a continuous stitch, in particular a buttonhole stitch. The continuous stitch may particularly preferably hold the stent structure and the graft together. A continuous stitch is particularly advantageous because it provides secure attachment and can be arranged in a continuous process. In addition, it provides further flexibility to attach fibers at different longitudinal positions, along the stent structure.
Particularly preferably, the fiber is attached with a conventional continuous stitch as known in the art. This allows for a particularly easy process to attach the graft to the stent structure. The fiber may be attached in the same process as the attachment of stent structure and graft, i.e. while arranging the suture. Alternatively, the fiber may also be attached to the suture after the attachment of stent structure and graft.
Preferably, endoprosthesis comprises at least two fibers, wherein the at least two fibers are connected via a common additional support string which is connected to the suture. A support string provides for a particularly efficient attachment process because multiple fibers can be attached at the string in one process step.
Preferably, the fiber comprises a knot connecting the fiber to the suture. A knot comprised by the fiber enables a particularly flexible attachment of the fiber to the suture and substantially any position on the suture.
The invention further relates to a method of manufacturing an endoprosthesis. The method is preferably performed to manufacture an endoprosthesis as described herein. The method comprises a first step of providing a stent structure, a graft, and a suture. The stent structure is attached to the graft via the suture. At least one fiber (e.g. thrombogenic fiber) is attached to the endoprosthesis (e.g. to the stent structure and/or to the graft) via the suture, in particular directly to the suture. In particular, the fiber may be attached via at least one of a loop, a knot, and a support string comprised by the fiber and/or the suture. The person skilled in the art will understand that the method may encompass steps of arranging the fiber, the suture, the stent structure and/or the graft as described herein.
In the following, the invention is described in detail with reference to the following figures, showing:
Any of the above-mentioned attachment mechanisms is suitable to attach the fibers 1 to the endoprosthesis 60 (e.g. to the stent and/or graft). The fibers 1 may remain attached by the suture, to the stent and/or to the graft after implantation using these attachment mechanisms. In the present embodiment, all the fibers are attached by the same mechanism. However, it would also be conceivable to attach different fibers 1 with different mechanisms and thus include several of the above-described mechanisms in one endoprosthesis. In particular, fibers with varying lengths between 2 and 50 mm may be attached to the stent and/or graft by the above-described mechanisms. Additionally or alternatively, fibers 1 may be attached to the stent and/or graft by the above-described mechanisms such that a free portion of the fiber may have a length of, and/or be able to extend away from the stent and/or graft by a distance of, between 2 and 50 mm. Similarly, the present embodiment shows a plurality of fibers 1 attached on the endoprosthesis 60 with a substantially uniform distribution. The person skilled in the art will understand that this is merely an exemplary embodiment and that any number of fibers 1 could be attached to the endoprosthesis 60, or with any distribution desired for a particular application. The fibers are preferably attached to the endoprosthesis 60 by the method according to the invention.
Number | Date | Country | Kind |
---|---|---|---|
20315008.1 | Jan 2020 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2021/051401 | 1/22/2021 | WO |